AdjuderaStart free

Supplier

TAKEDA FRANCE SAS

COURBEVOIE · FRA

Track this recordFree account — get alerted when a contract here runs out.

Awards

13

Total awarded

€307.1m

2 joint award(s) counted pro rata

Buyers

3

Sectors

1

Group: Takeda GmbH(inferred)

Reg. 785 750 266 00104

Contracts this supplier holds that are running out

All expiring contracts →

Awards

AwardedBuyerWinnerContract valuePublished
Vaccin contre la dengueVille de MarseilleTAKEDA FRANCE SAS—9 Dec 2025
PROTEINE C HUMAINCHU ROUEN NORMANDIELFB BIOMEDICAMENTS, TAKEDA FRANCE SAS€21,420,00019 Aug 2025
ADAMS13 RECOMBINANTE (APADAMTASE ALFA)Hospices Civils de LyonTAKEDA FRANCE SAS€7,067,77519 Jun 2025
IG POLYVALENTE HUMAINE IV 50 MG / ML (5%) POUDRE ET SOLVANT - Indication en présence d'AC anti Ig AHospices Civils de LyonTAKEDA FRANCE SAS€7,772,21529 Apr 2025
IG POLYVALENTE HUMAINE SOUS CUTANEE FORME INJECTABLE 200 MG / MLHospices Civils de LyonCSL BEHRING, GRIFOLS FRANCE, TAKEDA FRANCE SAS€313,987,70529 Apr 2025
IG POLYVALENTE SOUS CUTANEE - 1 injection toutes les 3 à 4 semainesHospices Civils de LyonTAKEDA FRANCE SAS€85,679,71029 Apr 2025
FACTEUR WILLEBRAND RECOMBINANTHospices Civils de LyonTAKEDA FRANCE SAS€27,966,37029 Apr 2025
LANADELUMABHospices Civils de LyonTAKEDA FRANCE SAS€2,158,24029 Apr 2025
INHIBITEUR DE LA C1 ESTERASE INDICATION : TRAITEMENT/PROPHYLAXIE AU LONG COURT DES CRISES D'OEDEMESHospices Civils de LyonTAKEDA FRANCE SAS€894,06229 Apr 2025
FACTEUR VIII RECOMBINANT - SUSOCTOCOG ALFAHospices Civils de LyonTAKEDA FRANCE SAS€3,946,43429 Apr 2025
FACTEUR VII HUMAINHospices Civils de LyonTAKEDA FRANCE SAS€1,983,70529 Apr 2025
FACTEUR BY PASSANT - COMPLEXE PROTHROMBIQUE ACTIVEHospices Civils de LyonTAKEDA FRANCE SAS€18,441,95529 Apr 2025
FACTEUR VIII RECOMBINANT - OCTACOG ALFAHospices Civils de LyonTAKEDA FRANCE SAS€35,789,90729 Apr 2025